5052552026-09-152026-09-155052552026-09-155052552026-09-15ChangeInManagementDomain15052552026-09-152026-09-15ChangeInManagementDomain15052552026-09-15ChangeInManagementDomain25052552026-09-152026-09-15ChangeInManagementDomain25052552026-09-15ResignationOfDirectorOrKeyManagerialPersonnelOrSeniorManagementPersonnelOrComplianceOfficerDomain15052552026-09-152026-09-15ResignationOfDirectorOrKeyManagerialPersonnelOrSeniorManagementPersonnelOrComplianceOfficerDomain1xbrli:pureGMMPFAUDLRGMM PFAUDLER LIMITED505255NOTLISTEDINE541A01023trueListed Entity (self)true2026-09-1515:20:0016:00:002The Board at its meeting held today i.e. September 15, 2026, noted resignation of Mr. Alexander Poempner as Group CFO & KMP of the Company, effective at the conclusion of the Board Meeting at which the unaudited financial results for the quarter and half year ended September 30, 2026 (Q2 FY27) will be approved, currently planned for November 4, 2026. The Board further noted that Mr. Poempner will continue with the organization until December 31, 2026, to ensure an orderly handover and provide transition support. The Board approved the appointment of Mr. Ankit Nayyar as Group CFO & KMP of the Company, effective at the conclusion of the said Board Meeting based on the recommendations of the Nomination & Remuneration Committee and the Audit Committee. The Board of Directors places on record its appreciation for Mr. Poempner’s leadership, dedication and contributions to the Company and wishes him all the best for the future.2026-09-15CessationResignationKey Managerial PersonnelChief Financial OfficerMr.Alexander Poempner2026-11-04trueAppointmentKey Managerial PersonnelChief Financial OfficerMr.Ankit Nayyar2026-11-04Mr. Nayyar joined the Company as Deputy CFO in May 2026 and has nearly two decades of experience across pharmaceuticals, speciality chemicals, manufacturing, and financial services. Most recently, as CFO of PI Health Sciences, he led global finance operations, M&A, deal structuring, and operational scale-up. He also played a key role in the Monsanto–Bayer integration, building finance capabilities and governance at Bayer & Monsanto India. Earlier, he held leadership roles at Pfizer, MSCI and Tata AIG Life Insurance. Academic Background: Chartered Accountant, Masters’ in Accounting & Finance from Manchester Business School (UK) and B.Com from Shri Ram College of Commerce.Mr.Alexander PoempnerChief Financial Officer2026-09-152026-11-04trueto pursue new opportunities